This product is a mouse monoclonal antibody that recognizes human EphA5. The antibody clone reacts with the the extracellular region (aa 304-467) of target. The binding of this antibody is specific for human EphA5 protein.
Figure 1 Validation of anti-EphA5 monoclonal antibody 11C12.
A, ELISA showing binding of 11C12 to human and rat EphA5. The monoclonal antibody 11C12 does not recognize mouse EphA5.
Staquicini, F. I., Qian, M. D., Salameh, A., Dobroff, A. S., Edwards, J. K., Cimino, D. F., ... & Liu, D. D. (2015). Receptor tyrosine kinase EphA5 is a functional molecular target in human lung cancer. Journal of Biological Chemistry, 290(12), 7345-7359.
Figure 2 Validation of anti-EphA5 monoclonal antibody 11C12.
D and E, receptor-mediated internalization (D) and receptor degradation (E) were also evaluated.
Staquicini, F. I., Qian, M. D., Salameh, A., Dobroff, A. S., Edwards, J. K., Cimino, D. F., ... & Liu, D. D. (2015). Receptor tyrosine kinase EphA5 is a functional molecular target in human lung cancer. Journal of Biological Chemistry, 290(12), 7345-7359.
Figure 3 Validation of anti-EphA5 monoclonal antibody 11C12.
D and E, receptor-mediated internalization (D) and receptor degradation (E) were also evaluated.
Staquicini, F. I., Qian, M. D., Salameh, A., Dobroff, A. S., Edwards, J. K., Cimino, D. F., ... & Liu, D. D. (2015). Receptor tyrosine kinase EphA5 is a functional molecular target in human lung cancer. Journal of Biological Chemistry, 290(12), 7345-7359.
Figure 4 The monoclonal antibody 11C12 radiosensitizes lung cancer in vivo.
A, growth inhibitory effect of the combined treatment of mAb 11C12 plus radiotherapy in vivo. Cohorts consisted of at least eight mice; the data are reported as mean tumor volumes ±S.D.
Staquicini, F. I., Qian, M. D., Salameh, A., Dobroff, A. S., Edwards, J. K., Cimino, D. F., ... & Liu, D. D. (2015). Receptor tyrosine kinase EphA5 is a functional molecular target in human lung cancer. Journal of Biological Chemistry, 290(12), 7345-7359.
Figure 5 The monoclonal antibody 11C12 radiosensitizes lung cancer in vivo.
C andD, quantification of Ki67-positive cells in tumor specimens collected 48 h after the end of each treatment. Photomicrographs illustrate Ki67-positive tumor cells.
Staquicini, F. I., Qian, M. D., Salameh, A., Dobroff, A. S., Edwards, J. K., Cimino, D. F., ... & Liu, D. D. (2015). Receptor tyrosine kinase EphA5 is a functional molecular target in human lung cancer. Journal of Biological Chemistry, 290(12), 7345-7359.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-0653CT | Recombinant Mouse anti-Human EPHA5 Monoclonal antibody (9C20C2,9C20G6) | ELISA, WB | |
ZG-0296J | Mouse Anti-EPHA5 Recombinant Antibody (ZG-0296J) | WB, ELISA | Mouse IgG |
VS3-QX372 | Mouse Anti-EPHA5 Recombinant Antibody (clone 46CT61.6.4) | WB, IHC | Mouse IgG1, κ |
There are currently no Customer reviews or questions for HPAB-0010-WJ. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.